Dimitri Messeri
Impact in
- Bioengineering top 10%
- Analytical Chemistry and Sensors
-
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Analytical Chemistry and Sensors 2
- Genetics 2
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- Alessandro Poscia (4 shared papers)Francesco Ricci (3 shared papers)Danila Moscone (3 shared papers)Mark P. Lowe (1 shared paper)David A.S Parker (1 shared paper)Mauro Botta (1 shared paper)Giuseppe Palleschi (2 shared papers)Aziz Amine (1 shared paper)
- Journals
- Biosensors and Bioelectronics (3 papers)Annals of Oncology (2 papers)Diabetes/Metabolism Research and Reviews (1 paper)Haematologica (1 paper)American Journal of Obstetrics and Gynecology (1 paper)
- Partner nations
- ItalyUnited KingdomPortugal
In The Last Decade
Dimitri Messeri
10 papers receiving 286 citations
Peers
Comparison fields: 5 of 58
- Bioengineering 55
- Genetics 60
- Electrochemistry 34
- Pathology and Forensic Medicine 49
- Endocrinology, Diabetes and Metabolism 34
Countries citing papers authored by Dimitri Messeri
This map shows the geographic impact of Dimitri Messeri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitri Messeri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitri Messeri more than expected).
Fields of papers citing papers by Dimitri Messeri
This network shows the impact of papers produced by Dimitri Messeri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitri Messeri. The network helps show where Dimitri Messeri may publish in the future.
Co-authors
The 25 scholars most cited alongside Dimitri Messeri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 67 | |
| 2 | 2001 | 56 | |
| 3 | 2018 | 55 | |
| 4 | 2006 | 43 | |
| 5 | 2005 | 41 | |
| 6 | 2004 | 12 | |
| 7 | Rituximab in combination with bendamustine or chlorambucil for the treatment of chronic lymphocytic leukemia: primary results from the randomised phase IIIb MABLE study | 2015 | 11 |
| 8 | 2020 | 6 | |
| 9 | 2020 | 3 | |
| 10 | 2005 | 1 |
About Dimitri Messeri
Dimitri Messeri is a scholar working on Bioengineering, Genetics, Cancer Research, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine, having authored 10 papers that have together received 295 indexed citations. Recurring topics across this work include Electrochemical sensors and biosensors (3 papers), Lymphoma Diagnosis and Treatment (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Breast Cancer Treatment Studies (2 papers), Analytical Chemistry and Sensors (2 papers), Diabetes Management and Research (2 papers), HER2/EGFR in Cancer Research (2 papers) and Pancreatic function and diabetes (1 paper). The work is most often cited by research in Bioengineering (55 citations), Genetics (60 citations), Electrochemistry (34 citations), Pathology and Forensic Medicine (49 citations) and Endocrinology, Diabetes and Metabolism (34 citations). Dimitri Messeri has collaborated with scholars based in Italy, United Kingdom and Portugal. Frequent co-authors include Alessandro Poscia, Francesco Ricci, Danila Moscone, Mark P. Lowe, David A.S Parker, Mauro Botta, Giuseppe Palleschi, Aziz Amine, Giorgio Dall’Oglio and Peter L. Johansson. Their work appears in journals such as Biosensors and Bioelectronics, Annals of Oncology, Diabetes/Metabolism Research and Reviews, Haematologica and American Journal of Obstetrics and Gynecology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.